HILS Insider Trading Activity and SEC Form 4 Filings
HILS insider trading summary
No open-market insider purchases or sales of Hillstream BioPharma Inc. (HILS) have been reported on SEC Form 4 in the past 12 months.
Latest HILS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 17, 2022 | Randy Milby | Chief Executive Officer | Buy | $390 (500 @ $0.78) |
| Jun 6, 2022 | Randy Milby | Chief Executive Officer | Buy | $350 (500 @ $0.70) |
| Jun 6, 2022 | Randy Milby | Chief Executive Officer | Buy | $160 (234 @ $0.68) |
| Jun 6, 2022 | Randy Milby | Chief Executive Officer | Buy | $67 (100 @ $0.67) |
| Jun 6, 2022 | Randy Milby | Chief Executive Officer | Buy | $67 (100 @ $0.67) |
| Jun 6, 2022 | Randy Milby | Chief Executive Officer | Buy | $44 (66 @ $0.67) |
| Jun 1, 2022 | Randy Milby | Chief Executive Officer | Buy | $1 (1 @ $0.94) |
| May 25, 2022 | Randy Milby | Chief Executive Officer | Buy | $632 (800 @ $0.79) |
| May 25, 2022 | Randy Milby | Chief Executive Officer | Buy | $154 (200 @ $0.77) |
| May 20, 2022 | Randy Milby | Chief Executive Officer | Buy | $473 (500 @ $0.95) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.